Using serological measures to estimate influenza incidence in the presence of secular trends in exposure and immuno-modulation of antibody response.

Our results highlight the need for improved methods when using antibody titers as an endpoint in settings where there is no clear influenza "off" season. Methods, like those presented here, that use titers from circulating and non-circulating strains may be key.